After Market Losers - Stocks Telegraph

FASTLY ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS

News

san francisco--(business wire)---- $fsly #cdn--fastly announces first quarter 2024 financial results.

REMITLY REPORTS FIRST QUARTER 2024 RESULTS

News

active customers up 36% year over year send volume up 34% year over year revenue up 32% year over year

EVERSPIN REPORTS UNAUDITED FIRST QUARTER 2024 FINANCIAL RESULTS

News

chandler, ariz.--(business wire)--everspin technologies, inc. (nasdaq: mram), the world's leading developer and manufacturer of magnetoresistive random access memory (mram) persistent memory solutions, today announced preliminary unaudited financial results for the first quarter ended march 31, 2024. “our first quarter revenue came in near the high end of our expectations while our gaap net income came in below our expectations,” said sanjeev aggarwal, president and chief executive officer. "we.

FRESHWORKS ANNOUNCES CEO TRANSITION

News

founder and ceo girish mathrubootham will transition to role of executive chairman, president dennis woodside to become chief executive officer & president founder and ceo girish mathrubootham will transition to role of executive chairman, president dennis woodside to become chief executive officer & president

OPENLANE, INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

carmel, ind. , may 1, 2024 /prnewswire/ -- openlane, inc. (nyse: kar), today reported its first quarter financial results for the period ended march 31, 2024.

ACCURAY REPORTS FISCAL 2024 THIRD QUARTER FINANCIAL RESULTS

News

madison, wis. , may 1, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) today reported financial results for the third quarter and nine-months ended march 31, 2024.

HERITAGE REPORTS FIRST QUARTER 2024 RESULTS

News

tampa, fla. , may 1, 2024 /prnewswire/ -- heritage insurance holdings, inc. (nyse: hrtg) ("heritage" or the "company"), a super-regional property and casualty insurance holding company, today reported first quarter of 2024 financial results.

ETSY, INC. REPORTS FIRST QUARTER 2024 RESULTS

News

brooklyn, n.y. , may 1, 2024 /prnewswire/ -- etsy, inc. (nasdaq: etsy), which operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world, today announced results for its first quarter ended march 31, 2024.

INGEVITY REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

north charleston, s.c.--(business wire)--ingevity corporation today reported its financial results for the first quarter 2024.

DOORDASH RELEASES FIRST QUARTER 2024 FINANCIAL RESULTS

News

san francisco--(business wire)--doordash, inc. (nasdaq: dash) today announced its financial results for the quarter ended march 31, 2024. in q1 2024, we set new quarterly records for total orders, marketplace gov, and revenue, while improving our net loss compared to a year ago. an evergreen goal for us is to execute at a high level against our operational targets, as this drives incremental scale and efficiency that we can reinvest to solve new problems for merchants, consumers, and dashers. w.

QORVO® ANNOUNCES FISCAL 2024 FOURTH QUARTER FINANCIAL RESULTS

News

greensboro, n.c., may 01, 2024 (globe newswire) -- qorvo® (nasdaq:qrvo), a leading global provider of connectivity and power solutions, today announced financial results for the company's fiscal 2024 fourth quarter ended march 30, 2024.

ZILLOW NAMES THIS YEAR'S BEST MARKETS FOR FIRST-TIME HOME BUYERS

News

top markets for first-time home buyers offer affordable options and peers living nearby st. louis is the top major market in the u.s. for first-time home buyers.  half of the 10 best markets for first-time buyers are in the midwest.

GETAROUND SECURES UP TO $50 MILLION IN ADDITIONAL FINANCING

News

san francisco--(business wire)--getaround (nyse: getr), the world's first connected carsharing marketplace, today announced that its existing debt facility with mudrick capital management has been expanded to provide the company with up to $50 million in additional capital. on april 29, 2024 getaround drew down the first $20 million of this capital. “earlier this year we proactively transitioned our leadership team and began restructuring our operations to create what we believe is a long-term,.

THE REAL GOOD FOOD COMPANY APPOINTS NEW SENIOR FOOD EXECUTIVES TO LEAD FINANCE, PROCUREMENT, SUPPLY CHAIN AND BUSINESS MANAGEMENT

News

respected finance executive jim behling appointed cfo to revitalize finance & reporting function, concurrent with hiring of john bissett, cpa as senior vice president of finance, controller

PAYCOM EXPANDS AUTOMATED PAYROLL WITH BETI INTO IRELAND

News

oklahoma city--(business wire)--paycom software, inc. (nyse: payc) (“paycom”), a leading provider of comprehensive, cloud-based human capital management software, announced it will expand its product offerings and geographic reach into ireland. this latest development includes access to beti®, an industry-first solution that empowers employees to do their own payroll. this expansion follows the company's recent introduction of payroll services in canada, mexico and the u.k. it also follows the.

ALLAKOS PROVIDES BUSINESS UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

News

san carlos, calif., march 14, 2024 (globe newswire) -- allakos inc. (the “company”) (nasdaq: allk), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the fourth quarter and full year ended december 31, 2023.

NETGEAR® REPORTS FIRST QUARTER 2024 RESULTS

News

san jose, calif.--(business wire)--netgear, inc. (nasdaq: ntgr), a global networking company that delivers innovative networking and internet connected products to consumers and businesses, today reported preliminary financial results for the first quarter ended march 31, 2024. first quarter 2024 net revenue of $164.6 million, a decrease of 9.0% from the comparable prior-year quarter. first quarter 2024 gaap operating loss of $21.6 million, or (13.2)% of net revenue, as compared to operating lo.

BARFRESH ANNOUNCES APPOINTMENT OF MARKO MATLA AS VICE PRESIDENT OF SUPPLY CHAIN & CO-MANUFACTURING

News

seasoned executive brings decades of expertise and industry partnerships to optimize supply chain operations strategic hire to amplify management's efforts towards significant sales uplift expected in fiscal year 2024 los angeles, may 01, 2024 (globe newswire) -- barfresh food group inc. (the “company” or “barfresh”) (nasdaq: brfh), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced the appointment of marko matla as vice president of supply chain & co-manufacturing. in his role, marko will oversee the supply chain operations, including spearheading the effort to bring on a new bottle co-manufacturer, collaborating with the company's network of production partners, and assisting with the launch of new products to ensure product supply and uncompromised service to customers.

PLUTONIAN ACQUISITION CORP. ANNOUNCES ADDITIONAL CONTRIBUTION TO TRUST ACCOUNT TO EXTEND PERIOD TO CONSUMMATE BUSINESS COMBINATION

News

new york , feb. 5, 2024 /prnewswire/ -- plutonian acquisition corp. (nasdaq: pltn, the " company "), a special purpose acquisition company, announced today that big tree cloud international group limited (" big tree cloud ") has deposited into the company's trust account (the " trust account ") an aggregate of $210,000, in order to extend the period of time the company has to complete a business combination for three additional months, from february 15, 2024 to may 15, 2024.  the company issued a promissory note to big tree cloud with a principal amount equal to the amount deposited.

ALTERNUS CLEAN ENERGY SET TO ACQUIRE OVER 80 MWP OF OPERATING SOLAR PV ACROSS EIGHT STATES IN THE U.S.

News

alternus clean energy set to acquire over 80 mwp of operating solar pv across eight states in the us. on completion will be immediately ebitda accretive

INTERACTIVE STRENGTH INC. (NASDAQ: TRNR) STRENGTHENS BALANCE SHEET BY PARTIALLY CONVERTING SENIOR LOAN TO EQUITY AND EXTENDING THE MATURITY

News

austin, tx, april 26, 2024 (globe newswire) -- via newmediawire – interactive strength inc. (nasdaq: trnr) (“trnr” or “the company”), maker of innovative specialty fitness equipment under the clmbr and forme brands, today announced that it had converted $3.0 million of the company's $8.0 million senior loan to equity and extended the maturity of the remaining loan balance to december 2024.

AVIAT NETWORKS ANNOUNCES FISCAL 2024 THIRD QUARTER AND NINE MONTH FINANCIAL RESULTS

News

total revenue of $111.6 million; up 33.7% year-over-year adjusted ebitda of $12.0 million; up 11.1% year-over-year cash from operations of $15.3 million in current quarter, $22.2 million year-to-date austin, texas , may 1, 2024 /prnewswire/ -- aviat networks, inc. ("aviat networks," "aviat," or the "company"), (nasdaq: avnw), the leading expert in wireless transport and access solutions, today reported financial results for its fiscal 2024 third quarter ended march 29, 2024. third quarter highlights grew core aviat revenue by 7%, driven by strong international sales and private network growth achieved 15th consecutive quarter of growth in both revenue and adjusted ebitda on a trailing twelve-month basis generated positive free cash flow in the quarter from both the core aviat and pasolink businesses secured first india microwave backhaul radio orders adding an addressable segment of $200 million third quarter financial highlights total revenues: $111.6 million, up 33.7% from the same quarter last year gaap results: gross margin 32.7%; operating expenses $31.5 million; operating income $5.0 million; net income $3.4 million; net income per diluted share ("net income per share") $0.27 non-gaap results: adjusted ebitda $12.0 million; gross margin 35.2%; operating expenses $28.5 million; operating income $10.8 million; net income $9.4 million; net income per share $0.73 net cash and marketable securities: $59.2 million; cash net of debt: $10.2 million "this quarter aviat achieved continued organic revenue and profitability growth," said pete smith, president and chief executive officer of aviat networks.

SCHRÖDINGER REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

new york--(business wire)--schrödinger today announced financial results for the first quarter of 2024.

CONDUENT REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

key q1 2024 highlights revenue: $921m pre-tax income: $127m adj. ebitda margin(1): 7.5% new business signings acv(2): $99m net arr activity metric(2) (ttm): $17m florham park, n.j.

EQUILLIUM REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

News

la jolla, calif.--(business wire)---- $eq--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on april 1, 2024, the compensation committee of equillium's board of directors granted an inducement award consisting of a nonstatutory stock option to purchase 10,000 shares of common stock to a new employee under equillium's 2024 inducement plan. the compensation committee ap.

DUN & BRADSTREET ANNOUNCES FIRST QUARTER EARNINGS RELEASE AND CONFERENCE CALL; PARTICIPATION IN UPCOMING INVESTOR CONFERENCE

News

jacksonville, fla.--(business wire)--dun & bradstreet holdings, inc. (“dun & bradstreet”) (nyse:dnb), a leading global provider of business decisioning data and analytics, today announced the date for the release of its first quarter 2024 earnings and its participation in an upcoming investor conference. first quarter 2024 earnings dun & bradstreet will release first quarter 2024 earnings before the market opens on may 2, 2024. a conference call to discuss its results will follow at.

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER 2024

News

revenue, gross margin and eps beat guidance  beverly, mass. , may 1, 2024 /prnewswire/ -- axcelis technologies, inc. (nasdaq: acls) today announced financial results for the first quarter ended march 31, 2024.

BIOSIG TECHNOLOGIES, INC. APPOINTS MR. ANTHONY AMATO TO POSITION OF CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY

News

westport, ct, april 30, 2024 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) or (“biosig” or "the company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced the appointment of mr. anthony amato to the position of chief executive officer (“ceo”), effective immediately.

GH RESEARCH REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

News

dublin, ireland, feb. 29, 2024 (globe newswire) -- gh research plc (nasdaq: ghrs), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today reported financial results for the year ended december 31, 2023, and provided updates on its business.

BON NATURAL LIFE LIMITED ANNOUNCES MAJOR BREAKTHROUGH IN APPLE POLYPHENOL TECHNOLOGY, SET TO BOOST FISCAL 2024 SALES

News

xi'an, china, dec. 12, 2023 (globe newswire) -- bon natural life limited (nasdaq: bon) ("bon" or the "company"), one of the leading bio-ingredient solution providers in the natural, health and personal care industries, today announced that the company has achieved significant breakthrough in apple polyphenol extraction technology. this development is set to drive considerable growth in bon's apple polyphenol products in the upcoming fiscal year.

PSYENCE BIOMED ANNOUNCES PHASE IIB CLINICAL TRIAL LISTING ON THE AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY (ANZCTR)

News

new york, april 17, 2024 (globe newswire) -- psyence biomedical ltd (nasdaq:pbm) (“psyence biomed” or the “company”) today announced that details of its upcoming phase iib clinical trial of nature-derived psilocybin in patients diagnosed with adjustment disorder following an advanced cancer diagnosis in the palliative care context has been listed on the australian new zealand clinical trials registry (“anzctr”), under registration number 12624000449538p.

MEDIACO ACQUIRES ESTRELLA MEDIA'S CONTENT AND DIGITAL OPERATIONS

News

new york & los angeles--(business wire)--mediaco holding inc. (nasdaq: mdia) (“mediaco”) today announced that it has acquired all of estrella media's network, content, digital, and commercial operations. among the estrella media brands joining mediaco are the estrellatv network and its influential linear and digital video content business, and estrella media's expansive digital channels, including its four fast channels – estrellatv, estrella news, cine estrellatv, and estrella games – and the.

EBAY INC. REPORTS FIRST QUARTER 2024 RESULTS

News

revenue of $2.6 billion, up 2% on an as-reported basis and up 2% on an fx-neutral basis gross merchandise volume of $18.6 billion, up 1% on an as-reported basis and roughly flat on an fx-neutral basis gaap and non-gaap earnings p er diluted share of $0.85 and $1.25, respectively gaap and non-gaap operating margin of 24.7% and 30.3%, respectively returned $638 million to shareholders in q1, including $499 million of share repurchases and $139 million paid in cash dividends san jose, calif. , may 1, 2024 /prnewswire/ -- ebay inc. (nasdaq: ebay), a global commerce leader that connects millions of buyers and sellers around the world, today reported financial results for its first quarter ended march 31, 2024.

KULICKE & SOFFA REPORTS SECOND QUARTER 2024 RESULTS

News

focuses on operational efficiency; increases repurchase activity singapore , may 1, 2024 /prnewswire/ -- kulicke and soffa industries, inc. (nasdaq: klic) ("kulicke & soffa," "k&s," "our," or the "company"), today announced financial results of its second fiscal quarter ended march 30, 2024. the company reported second quarter net revenue of $172.1 million, net loss of $102.7 million, representing eps of $(1.83) per fully diluted share, and non-gaap net loss of $53.2 million, representing non-gaap eps of $(0.95) per fully diluted share.

LICHEN CHINA LIMITED ANNOUNCED FINANCIAL RESULTS FOR FISCAL YEAR 2023

News

xiamen, china , april 5, 2024 /prnewswire/ -- lichen china limited (the "company" or "lichen china")(nasdaq: licn), a dedicated financial and taxation service provider in china, today announced its financial results for the fiscal year ended december 31, 2023. fy 2023 financial highlights: revenue increased approximately $5.95 million or 17.61% to approximately $39.76 million for the year ended december 31, 2023, as compared with approximately $33.81 million for the fiscal year ended december 31, 2022.

VISIONARY HOLDINGS INC. ANNOUNCEMENT OF MANAGEMENT CHANGE

News

toronto , april 23, 2024 /prnewswire/ -- visionary holdings inc. (the "company") (nasdaq: gv), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in canada and market partners in china, today announced on april 22, 2024, the board appointed mr. zhong chen as its new chief executive officer, effective immediately.

PROFESSIONAL DIVERSITY NETWORK, INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER AND FISCAL YEAR ENDED DECEMBER 31, 2023

News

chicago, march 29, 2024 (globe newswire) -- professional diversity network, inc. (nasdaq: ipdn), (“ipdn” or the “company”), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse and specialized individuals, today announced its financial results for the fourth quarter and fiscal year ended december 31, 2023. “2023 was a challenging year for pdn, considering the optimism we had as we closed out fiscal 2022.

CYTOMX THERAPEUTICS TO REPORT FIRST QUARTER 2024 RESULTS AND PROVIDE AN INITIAL CX-904 PHASE 1A CLINICAL DATA UPDATE ON MAY 8, 2024

News

- cx-904 (masked egfrxcd3 probody® t-cell engager) preliminary phase 1a results to be presented from ongoing dose escalation study -

CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS

News

boca raton, fla.--(business wire)--cross country healthcare, inc. (the “company”) (nasdaq: ccrn) today announced financial results for its first quarter ended march 31, 2024. selected financial information:       variance variance       q1 2024 vs q1 2024 vs dollars are in thousands, except per share amounts q1 2024 q1 2023 q4 2023 revenue $ 379,174     (39) %   (8) % gross profit margin*   20.4 %   (200) bps   (150) bps net income attributable to common stockholders $ 2,692     (91) %   (70) %.

EVIDENCE FOR CLENE'S CNM-AU8® AS A TREATMENT FOR REPAIR AND REMYELINATION IN MULTIPLE SCLEROSIS PRESENTED IN THE EMERGING SCIENCE SESSION AT THE 2024 AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

News

salt lake city, april 16, 2024 (globe newswire) -- clene inc. (nasdaq: clnn) (along with its subsidiaries, “clene”) and its wholly owned subsidiary clene nanomedicine, inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (als) and multiple sclerosis (ms), presented the phase 2 visionary-ms long term extension (lte) study results at the 2024 american academy of neurology (aan) annual meeting in denver.

CORRECTION: SAFE & GREEN HOLDINGS CORP ANNOUNCES REVERSE SPLIT OF THE COMPANY'S COMMON STOCK

News

miami fl, april 30, 2024 (globe newswire) -- safe & green holdings corp. (nasdaq: sgbx) (“safe & green holdings” or the “company”), a leading developer, designer, and fabricator of modular structures for residential, commercial, and point-of-care medicine, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-20. the reverse stock split will take effect as of 12:01 a.m. et, on thursday, may 2, 2024, and shares of safe and green holdings will trade on a post-split basis on nasdaq under the existing trading symbol, “sgbx,” at the market open on may 2, 2024.

ENTRAVISION UNVEILS “PODER LATINO” CONCERT SERIES

News

santa monica, calif.--(business wire)--entravision communications corporation announces the launch of its highly-anticipated “poder latino” concert series. this groundbreaking initiative represents a fusion of music, entertainment and community engagement aimed at mobilizing and informing the latino community. “we are excited to announce the launch of the 'poder latino' concert series, a unique platform poised at the intersection of entertainment and community," said nestor rocha, vice presiden.

FREIGHT TECHNOLOGIES, INC. REPORTS 30% YEAR-OVER-YEAR REVENUE GROWTH AND STRONG FR8FLEET VOLUMES FOR Q1 2024

News

30% year-over-year total revenue growth and 278% year-over-year volume growth in fr8fleet 30% year-over-year total revenue growth and 278% year-over-year volume growth in fr8fleet

GOLDEN SUN HEALTH TECHNOLOGY GROUP LIMITED ANNOUNCES RECEIPT OF NASDAQ DELISTING DETERMINATION AND PLAN TO APPEAL

News

shanghai, china, march 25, 2024 (globe newswire) -- golden sun health technology group limited, formerly known as golden sun education group limited (the “company” or “golden sun”) (nasdaq: gsun), a provider of tutorial services in china, today announced the company received a staff determination letter (the “letter”), on march 21, 2024, from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) notifying the company that, due to the company's failure to regain compliance with a minimum bid price of $1.00 per share requirement for continued listing on the nasdaq capital market, as set forth in nasdaq listing rule 5550(a)(2) (the "minimum bid requirement"), the staff has determined (the “determination”) that company's securities will be scheduled for delisting from nasdaq unless the company requests an appeal of this determination to a hearings panel (the "panel").

60 DEGREES PHARMACEUTICALS TO SPONSOR PILOT STUDY OF TAFENOQUINE FOR TREATMENT OF CANINE BABESIOSIS

News

60 degrees pharma (nasdaq: sxtp) will sponsor a study using tafenoquine, an fda-approved malaria drug, to treat canine babesiosis, a tick-borne disease.

HAVERTYS TO HOST FIRST QUARTER 2024 EARNINGS CONFERENCE CALL ON MAY 2, 2024

News

atlanta, ga / accesswire / april 24, 2024 / havertys (nyse:hvt; hvt.a) will release its first quarter 2024 financial results on wednesday, may 1, 2024, after the market closes. the company will host a conference call with investors and analysts on thursday, may 2, at 10:00 a.m.

BLUEJAY DIAGNOSTICS ANNOUNCES CLOSING OF $3.5 MILLION PUBLIC OFFERING

News

acton, mass., jan. 02, 2024 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, today announced the closing of its previously announced public offering of 2,692,308 shares of the company's common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,692,308 shares of common stock at a combined offering price of $1.30 per share (or pre-funded warrant in lieu thereof) and associated warrant. the warrants have an exercise price of $1.30 per share and are immediately exercisable upon issuance for a period of five years following the date of issuance.

MONOGRAM PROVIDES REGULATORY UPDATE FOLLOWING MEETING WITH FDA

News

510(k) submission with fda accelerated for early second half of 2024 austin, tx / accesswire / may 1, 2024 / monogram orthopaedics inc. (nasdaq:mgrm) ("monogram" or the "company"), an ai-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today provided an update related to the regulatory and commercialization path for its mbôs surgical system following its meeting with the u.s. food and drug administration (the "fda"). on april 19, 2024, monogram received written feedback from the fda regarding the company's q1 2023 pre-submission request.

PYXIS ONCOLOGY REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

News

boston, march 28, 2024 (globe newswire) -- pyxis oncology, inc. (nasdaq: pyxs), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that pyxis oncology's compensation committee of the board of directors granted restricted stock units with respect to an aggregate of 39,680 shares of pyxis oncology's common stock and stock options to purchase an aggregate of 49,600 shares of pyxis oncology's common stock to a newly hired employee. the awards were granted under the pyxis oncology, inc. 2022 inducement plan with a grant date of march 28, 2024, as an inducement material to the new employee entering employment with pyxis oncology, in accordance with nasdaq listing rule 5635(c)(4).

CBAK ENERGY REPORTS FOURTH QUARTER AND FULL YEAR 2023 UNAUDITED FINANCIAL RESULTS

News

dalian, china, march 15, 2024 /prnewswire/ -- cbak energy technology, inc. (nasdaq: cbat) ("cbak energy," or the "company") a leading lithium-ion battery manufacturer and electric energy solution provider in china, today reported its unaudited financial results for the fourth quarter and full year ended december 31, 2023. fourth quarter of 2023 financial highlights net revenues from sales of batteries were $36.8 million, an increase of 30.9% from $28.1 million in the same period of 2022.

UNITY APPOINTS MATTHEW BROMBERG AS NEW CEO

News

san francisco--(business wire)--unity (nyse: u) (the “company”), the world's leading platform of tools for creators to build and grow real-time games, apps, and experiences across multiple platforms, today announced that matthew bromberg has been appointed chief executive officer, president, and a member of the unity board of directors, effective may 15, 2024. interim chief executive officer jim whitehurst has been appointed executive chair of the unity board while roelof botha will transition.

ESS INC. SCHEDULES FIRST QUARTER 2024 FINANCIAL RESULTS CONFERENCE CALL

News

wilsonville, ore.--(business wire)--ess tech, inc. (“ess,” “ess inc.”) (nyse:gwh), a leading manufacturer of long-duration energy storage systems (ldes) for commercial and utility-scale applications, today announced that it will hold a conference call on tuesday, may 7, 2024 at 5:00 p.m. edt to discuss financial results for its first quarter 2024 ended march 31, 2024. the news release announcing the first quarter 2024 financial results will be disseminated on may 7, 2024 after the market closes.

TITAN INTERNATIONAL, INC. REPORTS FIRST QUARTER FINANCIAL PERFORMANCE

News

delivers solid profitability with adjusted ebitda of $50 million and adjusted eps of $0.29 integration of carlstar driving 'one stop shop' positioning in ag and consumer segments for long-term growth west chicago, ill. , may 1, 2024 /prnewswire/ -- titan international, inc. (nyse: twi) ("titan" or the "company"), a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products, today reported financial results for the first quarter ended march 31, 2024.

ENVISTA REPORTS FIRST QUARTER 2024 RESULTS

News

brea, calif. , may 1, 2024 /prnewswire/ -- envista holdings corporation (nyse: nvst) today announced results for the first quarter of 2024.

NOVABAY PHARMACEUTICALS ANNOUNCES NEW AND ENHANCED DIRECT-TO-CONSUMER MARKETING TO EFFICIENTLY ENGAGE CUSTOMERS AND DRIVE AVENOVA SALES

News

emeryville, calif.--(business wire)--novabay® pharmaceuticals, inc. (nyse american: nby), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message communications (sms) and targeted email programs aimed at enhancing the avenova® brand while engaging with customers to drive online sales of avenova products. the new and enhanced programs build upon the company's past highly productive marketing.

RUBICON RECEIVES NOTICE OF NON-COMPLIANCE WITH NYSE TRADING SHARE PRICE AND MARKET CAPITALIZATION LISTING RULES

News

new york--(business wire)--rubicon technologies, inc. (“rubicon” or the “company”) (nyse: rbt), a leading provider of technology solutions for waste, recycling, and fleet operations, today announced that on march 18, 2024 it received a notice (the “notice”) from the new york stock exchange (the “nyse”) informing the company that it is no longer in compliance with sections 802.01b and 802.01c of the nyse listed company manual. the company was notified by the nyse that it was not in compliance wi.

PRISM MARKETVIEW – WEEKLY MARKET REPORT – APRIL 26, 2024

News

prism market pulse: equities rally amid mixed big tech earnings; economic shifts and sector-specific highlights new york, n.y., april 26, 2024 – prism marketview – equities were higher through the morning into midday trading as the s&p 500 and nasdaq are set to snap their three- and four-week losing streaks.

PHOENIX MOTOR STRENGTHENS CAPITAL STRUCTURE BY NEGOTIATING KEY WAIVER WITH NOTE HOLDER

News

anaheim, ca / accesswire / april 25, 2024 / phoenix motor inc. (nasdaq:pev) (the "company"), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it signed a waiver agreement with jak opportunities ii llc, one of the company's principal investors, eliminating a potential $12 million convertible promissory note issuance related to a securities purchase agreement (spa) signed in november 2023. "recent capital raising activities have provided us with a solid foundation to accelerate our growth initiatives while eliminating the need to incur further dilution related to the spa," said denton peng, ceo of phoenix motor.

MGO GLOBAL ANNOUNCES 2023 YEAR-END RESULTS

News

new stand flagpoles' business helps to achieve 411% in year-over-year revenue growth miami, fl, new york, ny and london, uk / accesswire / april 3, 2024 / mgo global inc. (nasdaq:mgol), a digitally-native, lifestyle brand portfolio company, ("mgo" or the "company" or "mgo global"), today announced its financial results for the year ended december 31, 2023. maximiliano ojeda, co-founder, chairman and ceo of mgo global, stated, "i am pleased to report that we finished 2023 on a strong note, with our new stand flagpole business delivering solid revenue performance and the messi store demonstrating notable double-digit growth.

MOBILE-HEALTH NETWORK SOLUTIONS OPENS NEW RETAIL PHARMACY

News

singapore, april 30, 2024 (globe newswire) -- mobile-health network solutions (nasdaq: mndr) (“manadr” or “the company”), a leading asia-pacific telehealth provider, today announced the grand opening of manapharma pharmacy, the company's new retail pharmacy, at 12 noon local time.

PURECYCLE SCHEDULES FIRST QUARTER 2024 CORPORATE UPDATE

News

orlando, fl / accesswire / april 23, 2024 / purecycle technologies, inc. (nasdaq:pct), a u.s.-based company revolutionizing plastic recycling, will host a conference call on tuesday, may 7, 2024, to provide an update on recent corporate developments. a press release discussing such developments and other activity from the first quarter will be provided prior to the conference call.

SANGAMO THERAPEUTICS TO PRESENT NEUROLOGY-FOCUSED PRE-CLINICAL DATA FROM ITS EPIGENETIC REGULATION, CAPSID DELIVERY AND GENOME ENGINEERING PLATFORMS AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)

News

richmond, calif.--(business wire)--sangamo therapeutics to present neurology pre-clinical data from its epigenetic regulation, capsid delivery and genome engineering platforms at asgct.

PAVMED SUBSIDIARY, VERIS HEALTH, SIGNS MEMORANDUM OF UNDERSTANDING WITH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE

News

parties to implement a pilot program of the veris cancer care platform new york , april 30, 2024 /prnewswire/ -- pavmed inc. (nasdaq: pavm) ("pavmed" or the "company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary veris health inc. ("veris"), today announced that veris and the ohio state university comprehensive cancer center – arthur g. james cancer hospital and richard j.

NEUROONE® CEO DAVE ROSA FEATURED ON BLOOMBERG TECHNOLOGY

News

eden prairie, minn., april 10, 2024 (globe newswire) -- neuroone medical technologies corporation (nasdaq: nmtc) (“neuroone” or the “company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by chief executive officer dave rosa on bloomberg television's bloomberg technology. a replay of the segment, which aired live yesterday, can be viewed at neuroone-bloomberg.

APREA THERAPEUTICS ANNOUNCES PRESENTATIONS ON ITS NEXT GENERATION WEE1 INHIBITOR, APR-1051, AND A NOVEL MACROCYCLIC ATR INHIBITOR, ATRN-119, AT AACR ANNUAL MEETING 2024

News

pre-clinical findings underscore the potential of apr-1051, a next-generation wee1 kinase inhibitor, to be a well-tolerated and effective treatment for cyclin e-overexpressing cancers

RED CAT SUCCESSFULLY PASSES FIELD TESTING WITH DOODLE LABS AGAINST ELECTRONIC WARFARE TECHNOLOGY IN UKRAINE

News

san juan, puerto rico, april 25, 2024 (globe newswire) -- red cat holdings, inc. (nasdaq: rcat) ("red cat"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced it has successfully passed electronic warfare (ew) testing in ukraine with doodle labs. the successful test is part of a continuous innovation cycle that began in may 2023 with a partnership between doodle labs and red cat for its u.s. army short range reconnaissance (srr) program prototype.

SILO PHARMA ANNOUNCES POSITIVE RESULTS FOR INTRANASAL PTSD TREATMENT

News

intranasal delivery of spc-15 shows rapid and effective drug exposure for ptsd therapy sarasota, fl, april 23, 2024 (globe newswire) -- silo pharma, inc. (nasdaq: silo) (“silo” or the “company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced positive data in the final validation report from the recent pharmacokinetic (pk) study of spc-15, an intranasal prophylactic treatment for anxiety and post-traumatic stress disorder (ptsd). the pk study was conducted as part of non-glp small animal dose-ranging study of spc-15 completed in february 2024.

CLIMB GLOBAL SOLUTIONS REPORTS FIRST QUARTER 2024 RESULTS

News

q1 2024 net sales up 9% yoy to $92.4 million, with adjusted gross billings up 16% to $355.3 million q1 2024 net sales up 9% yoy to $92.4 million, with adjusted gross billings up 16% to $355.3 million

1847 PROVIDES UPDATE ON THE SALE OF 1847 CABINETS INC.

News

new york, ny / accesswire / april 29, 2024 / 1847 holdings llc ("1847" or the "company") (nyse american:efsh), a holding company specializing in identifying over-looked, deep value investment opportunities in middle market businesses, today provided an update on the sale of 1847 cabinets inc. as previously announced on april 23, 2024, the company executed a non-binding letter of intent ("loi") with a prospective strategic buyer to sell all of the assets of 1847 cabinets inc. ("1847 cabinets"). under the terms of the loi, the buyer has proposed an enterprise value of $27.6 million for the acquisition of all of the assets of 1847 cabinets, including $11.5 million in earn-out payments over a three-year period, representing a 5.91x multiple of 2023 ebitda of approximately $4.7 million.

ZEVIA TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

News

los angeles--(business wire)--zevia pbc (“zevia” or the “company”) (nyse: zvia), the company bringing great tasting, zero sugar beverages made with simple, plant-based ingredients across all usage occasions to households across income levels, today announced that its president and chief executive officer, amy taylor and chief financial officer, girish satya will participate in two upcoming investor conferences. these include the goldman sachs global staples forum, to be held may 14, 2024 in new.

HUDSON TECHNOLOGIES REPORTS FIRST QUARTER 2024 RESULTS

News

woodcliff lake, n.j., may 01, 2024 (globe newswire) -- hudson technologies, inc. (nasdaq: hdsn) announced results for the first quarter ended march 31, 2024.

PREDICTIVE ONCOLOGY ANNOUNCES ABSTRACT ACCEPTED FOR PRESENTATION AT THE 2024 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

News

pittsburgh, april 24, 2024 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a leader in ai-driven drug discovery and biologics, today announced that an abstract has been accepted for presentation at the 2024 american society of clinical oncology (asco) annual meeting, which is being held may 31-june 4, 2024, in chicago, il.

TEVOGEN BIO ANNOUNCES FULL YEAR 2023 FINANCIAL RESULTS AND UPCOMING OPERATIONAL OBJECTIVES

News

acquire cell therapy manufacturing facility with clinical and commercial capabilities further exactcell platform for additional clinical trials based on successful completion of poc highlight full year financial results and clarify key financial items warren, n.j., may 01, 2024 (globe newswire) -- tevogen bio holdings inc. (“tevogen” or “tevogen bio”) (nasdaq: tvgn), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified t cell therapeutics in oncology, neurology, and virology, announced financial results for full year 2023, business highlights, and upcoming operational objectives.

LENDINGTREE REPORTS FIRST QUARTER 2024 RESULTS

News

insurance segment strength and operating leverage drive strong results at top or above of forecasted range consolidated revenue of $167.8 million gaap net income of $1.0 million or $0.08 per diluted share variable marketing margin of $69.4 million adjusted ebitda of $21.6 million adjusted net income per share of $0.70 charlotte, n.c. , april 30, 2024 /prnewswire/ -- lendingtree, inc. (nasdaq: tree), operator of lendingtree.com, the nation's leading online financial services marketplace, today announced results for the quarter ended march 31, 2024.

PAYLOCITY ANNOUNCES Q3 FY24 EARNINGS CONFERENCE CALL

News

schaumburg, ill., april 18, 2024 (globe newswire) -- paylocity holding corporation (nasdaq: pcty), a leading provider of cloud-based hr and payroll software solutions, today announced that it has scheduled a conference call to review its third quarter fiscal 2024 results for thursday, may 2nd at 4:30 pm central time (5:30 pm eastern time).

SHAREHOLDERS OF ALLOVIR, INC. SHOULD CONTACT LEVI & KORSINSKY BEFORE MARCH 19, 2024 TO DISCUSS YOUR RIGHTS - ALVR

News

new york, ny / accesswire / march 19, 2024 / if you suffered a loss on your allovir, inc. (nasdaq:alvr) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/allovir-inc-lawsuit-submission-form?prid=71800&wire=1 or contact joseph e. levi, esq.

ARAMCO AND GCT SEMICONDUCTOR HOLDING, INC. SIGN MOU TO ACCELERATE THE DEVELOPMENT OF THE 4G AND 5G ECOSYSTEM IN SAUDI ARABIA

News

san jose, calif. & dhahran, saudi arabia--(business wire)--aramco has signed a memorandum of understanding (mou) with gct semiconductor holding inc. (“gct”) (nyse: gcts), a leading designer and supplier of advanced 5g and 4g semiconductor solutions, setting the stage for a strategic collaboration that would further develop the 4g/5g ecosystem in saudi arabia for both mission-critical and public safety networks. the collaboration aims to design and co-develop chipsets and modules tailored for lt.

SEACOR MARINE ANNOUNCES FIRST QUARTER 2024 RESULTS

News

houston, may 01, 2024 (globe newswire) -- seacor marine holdings inc. (nyse: smhi) (the “company” or “seacor marine”), a leading provider of marine and support transportation services to offshore energy facilities worldwide, today announced results for its first quarter ended march 31, 2024.

LANZATECH ANNOUNCES DATE FOR FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL

News

chicago, april 18, 2024 (globe newswire) -- lanzatech global, inc. (nasdaq: lnza) (“lanzatech” or the “company”), the carbon recycling company transforming waste carbon into sustainable raw materials, today announced that it will issue its first quarter 2024 financial results before the market opens on thursday, may 9, 2024. a conference call will be held that same day at 8:30 a.m. et to review the company's financial results, discuss recent events and conduct a question-and-answer session.

FLORA GROWTH CORP. APPLAUDS REPORTED HISTORIC DEA MOVE TO RESCHEDULE CANNABIS

News

fort lauderdale, florida--(newsfile corp. - may 1, 2024) - flora growth corp. (nasdaq: flgc) ("flora" or the "company"), a consumer-packaged goods leader and pharmaceutical distributor, is applauding the reported historic move by the u.s. drug enforcement administration ("dea") to reclassify cannabis from its list of schedule i drugs to schedule iii, following a recommendation from the federal health and human services department ("hhs"). "this expected rescheduling would come shortly after germany's legalization of recreational cannabis becoming effective earlier in april.

BIORESTORATIVE THERAPIES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON MAY 14, 2024

News

- company to provide update on exciting new commercial agreement, as well as phase 2 clinical trial in spine and preclinical development program in obesity -

IN8BIO DOSES FIRST PATIENT IN PHASE 2 CLINICAL TRIAL OF INB-400 IN NEWLY DIAGNOSED GLIOBLASTOMA

News

new york, april 30, 2024 (globe newswire) -- in8bio, inc . (nasdaq: inab), a clinical-stage biopharmaceutical company advancing innovative gamma-delta t cell therapies, announced today that the first patient in its phase 2 clinical trial evaluating inb-400 in patients with newly diagnosed glioblastoma multiforme (gbm) has been successfully dosed at the cleveland clinic in ohio.

LONGEVERON TO PRESENT AT THE PLANET MICROCAP SHOWCASE

News

miami, april 25, 2024 (globe newswire) -- longeveron inc. (nasdaq: lgvn), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the planet microcap showcase, taking place may 1-2, 2024. details for the company's presentation:   date: wednesday, may 1, 2024   time: 4:30 p.m.

LEXARIA TO RECEIVE $4.7 MILLION GROSS PROCEEDS IN WARRANT EXERCISE AND ISSUANCE

News

kelowna, bc / accesswire / april 30, 2024 / lexaria bioscience corp. (nasdaq:lexx)(nasdaq:lexxw) (the "company" or "lexaria"), a global innovator in drug delivery platforms announces it has entered into a warrant exercise agreement with an existing accredited investor to exercise in full certain existing warrants to purchase an aggregate 2,917,032 shares of its common stock, as to 1,618,330 warrants exercised at an exercise price of $0.97 per share, and 1,298,702 warrants exercised at $2.185 per share, originally issued in october 2023 and february 2024, respectively. with this exercise, there are zero remaining warrants exercisable at $0.97 and 259,741 warrants unexercised at $2.185.

BRÜUSH RECEIVES ADDITIONAL DELISTING NOTIFICATION TO ADDRESS AT HEARING

News

vancouver, bc / accesswire / april 19, 2024 / bruush oral care inc. (nasdaq:brsh) (the "company"), today announced that it received a notice (the "notice") from the listing qualifications department of the nasdaq stock market, llc ("nasdaq") on april 15, 2024 notifying the company that because it is not compliant with nasdaq's audit committee requirements as set forth in listing rule 5605 (the "audit committee requirements"), this deficiency serves as an additional basis for delisting the company's securities from nasdaq. this deficiency will be considered by the hearings panel (the "panel") at a hearing that has been scheduled for april 25, 2024 (the "hearing") to address the company's other current deficiencies.

INMUNE BIO INC. PROVIDES UPDATE ON TWO PATIENTS FROM THE PHASE 1B ALZHEIMER'S DISEASE TRIAL WHO CONTINUE TO RECEIVE XPRO™ UNDER COMPASSIONATE USE FOR OVER THREE YEARS

News

boca raton, florida, april 30, 2024 (globe newswire) --   inmune bio inc.  (nasdaq: inmb) (the “company”), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, is pleased to share an update on two patients from the phase 1b trial completed in 2021 who have continued to receive xpro™ for treatment of alzheimer's disease (ad) for more than three years under the australian compassionate use program known as the  special access scheme  (sas).

QUANTUM-SI ANNOUNCES UPGRADES TO ANALYSIS SOFTWARE THAT WILL PROVIDE CUSTOMERS WITH HIGHER DATA OUTPUT AND PRECISION AND SHORTER PROCESSING TIME

News

branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced upgrades to its platinum® analysis software to reduce processing time and increase output and precision of next-generation protein sequencing™ (ngps) data from the platinum® instrument. “a core component of our platinum analysis software is a database of predicted kinetic signatures that today, contains nearly two million parameters and.

PRESTIGE WEALTH INC. ANNOUNCES FIRST HALF OF FISCAL YEAR 2023 FINANCIAL RESULTS

News

hong kong , dec. 1, 2023 /prnewswire/ -- prestige wealth inc. (nasdaq: pwm) (the "company" or "prestige wealth"), a wealth management and asset management services provider based in hong kong, today announced its unaudited financial results for the six months ended march 31, 2023. mr. hongtao shi, the company's chairman and chief executive officer, commented, "reflecting upon the first half of fiscal year 2023, we faced some undeniable headwinds in our wealth management business, largely stemming from the ramifications of the covid-19 pandemic.

AIR INDUSTRIES GROUP TO PRELIMINARY REPORT Q4 AND FY 2023 RESULTS ON APRIL 1, 2024 AND SCHEDULES EARNINGS CONFERENCE CALL

News

bay shore, n.y.--(business wire)---- $airi--air industries group (nyse american: airi), a leading manufacturer of precision components and assemblies for large aerospace and defense prime contractors, today announced that it plans to release its preliminary q4 fiscal and full-year 2023 results after the market closes on monday, april 1, 2024. conference call information at 4:30 et that day, the company will also host a conference call to discuss its results and 2024 business outlook. individuals can acce.

ENVIVA RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING

News

bethesda, md. , april 8, 2024 /prnewswire/ -- enviva inc. (nyse: eva) ("enviva" or the "company") today announced that on april 2, 2024, the company received notice from the new york stock exchange (the "nyse") that it is not in compliance with section 802.01e of the nyse listed company manual due to a delay in filing its annual report on form 10-k for the year ended december 31, 2023, with the securities and exchange commission (the "sec").

WORKHORSE GROUP ADDS MILEA TRUCK SALES AND LEASING, EXPANDING NEW YORK PRESENCE

News

cincinnati, april 24, 2024 (globe newswire) -- workhorse group inc. (nasdaq: wkhs ) (“workhorse” or “the company”), an american technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced the addition of milea truck sales and leasing to its growing certified dealer network. with locations in the bronx and brooklyn, milea truck sales and leasing marks workhorse's second dealer partner in new york state , 12th dealer nationwide, and its latest addition to the certified dealer program.

KARTOON STUDIOS INC. COMPLETES FIRST TRANCHE OF REGISTERED DIRECT OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS FOR UP TO $7.0 MILLION; CLOSES INITIAL PURCHASE OF $4.0 MILLION OF COMMON STOCK AND PRE-FUNDED WARRANTS

News

beverly hills, calif., april 23, 2024 (globe newswire) -- kartoon studios inc. (nyse american: toon) (“kartoon studios” or the “company”), a global end-to-end creator, producer, distributor, marketer, and licensor of entertainment brands, today announced the consummation of the initial closing of a registered direct offering (the “offering”) to a certain institutional investor (the “investor”) pursuant to a securities purchase agreement, dated april 18, 2024, of up to 7,000,000 shares of its common stock, par value $0.001 per share (the “common stock”), and/or pre-funded warrants to purchase shares of common stock (the “pre-funded warrants”), of which 3,900,000 shares and 100,000 pre-funded warrants were issued and sold on april 23, 2024. an additional 3,000,000 shares and/or pre-funded warrants may be issued and sold to the investor at the sole option of the investor, at $1.00 per share of common stock and $0.99 per pre-funded warrant, in up to three additional closings of at least $1,000,000 in gross proceeds each, and to occur no later than one hundred eighty (180) days following april 18, 2024. the company received aggregate gross proceeds of $4,000,000 from the initial closing, prior to deducting placement agent fees and other offering expenses and may receive up to an additional $3 million in gross proceeds pursuant to the subsequent closings, prior to deducting placement agent fees and other offering expenses.

AURINIA UNDERSCORES ENDURING COMMITMENT TO PEOPLE LIVING WITH LUPUS NEPHRITIS THROUGH INNOVATIVE ADVOCACY AND EDUCATION INITIATIVES FOR LUPUS AWARENESS MONTH

News

rockville, md. & edmonton, alberta--(business wire)--in recognition of lupus awareness month, aurinia pharmaceuticals inc. (nasdaq: auph) (aurinia or the company), today announced several initiatives to improve understanding of the seriousness of lupus nephritis (ln) and the need for frequent screening and appropriate management, including an innovative disease state education campaign for rheumatologists. aurinia is on a mission to tackle the toughest challenges that the ln community faces thr.

INMED APPOINTS DR. DAVID G. MORGAN, PHD, A LEADING ALZHEIMER'S EXPERT, TO THE COMPANY'S SCIENTIFIC ADVISORY BOARD

News

vancouver, british columbia--(newsfile corp. - april 18, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a leader in the research, development, manufacturing, and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today announced the addition of dr. david g. morgan, a renowned leader in neurodegenerative disease to its scientific advisory board ("sab") reinforcing the company's commitment to advancing it's inm-901 program in the treatment of alzheimer's disease.

PRAIRIE OPERATING CO. ANNOUNCES UNANIMOUS APPROVAL OF GENESIS OIL AND GAS DEVELOPMENT PLAN ADDING MULTI-YEAR INVENTORY OF DEVELOPMENT DRILLING LOCATIONS

News

houston, texas, march 14, 2024 (globe newswire) -- prairie operating co. (nasdaq: prop) (the “company” or “prairie”) today announced the colorado energy and carbon management commission (“ecmc”) approved the company's genesis i oil & gas development plan (“ogdp”).

VECTOR GROUP REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

miami--(business wire)--vector group ltd. (nyse:vgr) today announced financial results for the three months ended march 31, 2024. “vector group delivered strong performance in the first quarter driven by continued growth of our montego brand,” said howard m. lorber, president and chief executive officer of vector group ltd. “our proven ability to increase montego's market share and profitability underscores the effectiveness of our brand strategy, market analysis, broad-based distribution, and.

PROCORE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS

News

carpinteria, calif.--(business wire)---- $pcor--procore technologies, inc. (nyse: pcor), the leading global provider of construction management software, today announced financial results for the first quarter ended march 31, 2024. “the highly complex and collaborative nature of our industry underscores the importance of our mission to connect everyone in construction on a global platform,” said tooey courtemanche, founder and ceo of procore. “our trusted, innovative platform mirrors what the industry ne.

CABALETTA BIO REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

– first patient dosed with caba-201 in the reset™ (restoring self-tolerance) clinical trial program – – initial clinical data from each of the first patients in the reset-myositis™ and reset-sle™ trials anticipated in 1h24; longer term follow-up on these and additional patients to be reported in 2h24 – – reset-ssc™ (systemic sclerosis) and reset-mg™ trials initial clinical data anticipated to be reported in 2h24 – – rare pediatric disease designation granted by fda for caba-201 in juvenile dermatomyositis – – cash runway into 1h26 with cash, cash equivalents and short-term investments of $241.2 million as of december 31, 2023 – philadelphia, march 21, 2024 (globe newswire) -- cabaletta bio, inc. (nasdaq: caba), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today reported financial results for the fourth quarter and full year ended december 31, 2023, and provided a business update. “throughout the past year, we set the foundation to enable an efficient development strategy for caba-201 across a broad range of autoimmune diseases.